One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25 years. Among older people with diabetes, 30-45% are affected by frailty (Frailty) The risk of frailty increases with increasing HbA1c. The incidence of atherosclerotic cardiovascular disease (ASCVD) doubles with age, with a prevalence of 38.5% for coronary heart disease (CHD), 13% for stroke and 12% for peripheral arterial disease (PAD) in people aged ≥70 years. In addition to their glucose-controlling effect, new antidiabetic drugs have organ-protective benefits and have brought about a paradigm shift in diabetology.
Autoren
- Dr. med. Young Hee Lee-Barkey
- PD Dr. rer. nat. Bernd Stratmann
- Prof. Dr. med. Susanne Reger-Tan
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Type 2 diabetes and heart failure: a bidirectional relationship
Proactive preventive measures can reduce the burden of disease
- Dementia
Delirium risks and treatment strategies
- Colorectal cancer screening
Results of the population-based PREEMPT-CRC study
- Study report: TBS v3 and v4 in comparison
Analysis of OsteoLaus study data
- Atopic dermatitis: proven therapeutic principles and innovations
From healthcare research to precision medicine
- SGLT2 inhibitors and glucocorticoids
Protective effect on kidney function is maintained
- Study report: Nicotinamide for skin cancer prevention
Cohort study analyzed data from over 30,000 patients
- Psychooncology